The 'Underperform' rating suggests that the analyst expects Stem's stock to do worse than the market average. However, the increase in price target from $5 to $6 indicates a slightly more positive outlook than before. This could lead to mixed reactions in the market, but overall, the negative rating is likely to have a greater impact.